Greater Bay Area Chapter

www.lls.org/gba

Browse chapters by location

The Word:

donate

Emerging Therapies and Survivorship Conference


The Leukemia & Lymphoma Society (LLS) is pleased to bring the latest advances in blood cancer research, clinical trials and disease management to Northern California patients and their caregivers.
 

Please mark your calendars for this special patient conference. Emerging Therapies is a free educational program, but space is limited and registration is required.

Saturday, January 25, 2014
8:30 a.m. - 12:30 p.m.
Hyatt Regency San Francisco
5 Embarcadero Center, San Francisco, CA 94111

How to register

To reserve your space, please complete the registration form at bit.ly/emergingtherapies

Program Agenda

  • 8:30 a.m. Registration and Breakfast
  • 9:00 a.m. Welcome Message from LLS
  • 9:15 a.m. Keynote: Dan Shapiro, Ph.D.
    A Funny Thing Happened On The Way to Chemotherapy
  • 10:15 a.m. Exhibitor Sessions
  • 10:30 a.m. Concurrent Breakout Sessions
    • Acute Myeloid Leukemia (New!): Bruno Medeiros, M.D.
      Associate Professor of Medicine, Division of Hematology, Stanford University School of Medicine
    • Chronic Lymphoid Leukemia: Steven Coutre, M.D.
      Associate Professor of Medicine, Division of Hematology, Stanford University School of Medicine
    • Chronic Myeloid Leukemia: Neil Shah, M.D., Ph.D.
      Distinguished Professor in Hematology/Oncology, Edward S. Agenda Distinguished Professor; Leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center at UCSF 
    • Multiple Myeloma: Jeffrey Wolf, M.D.
      Clinical Professor of Medicine and Director of the Myeloma Institute, Helen Diller Family Comprehensive Cancer Center, UCSF 
    • Myelodyplastic Syndromes: Peter Greenberg, M.D.
      Professor Emeritus, Medicine - Hematology, Stanford University School of Medicine
    • Non-Hodgkin Lymphoma (High Grade/Aggressive): Lawrence Kaplan, M.D.
      Clinical Professor of Medicine, Director, Adult Lymphoma Program, Division of Hematology/Oncology, UCSF
    • Non-Hodgkin Lymphoma (Low Grade/Indolent): C. Babis Andreadis, M.D., MSCE
      Associate Professor, Hemeatology and BMT Program, Helen Diller Family Comprehensive Cancer Center, UCSF
    • Pediatric Blood Cancers (New!): Michelle Hermiston, M.D., Ph.D.
      Associate Professor, Division of Pediatric Hematology/Oncology, UCSF, UCSF Benioff Children's Hospital

The 2014 Northern California Emerging Therapies and Survivorship conference is made possible by the generosity of our partners and sponsors.

2014 Partners: Association of Northern California Oncologists, Marin Specialty Care, Redwood Regional Oncology Center, Stanford Cancer Center, and University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, Sutter Medical Center of Santa Rosa

2014 Sponsors: Millennium, Genentech, Onyx Pharmaceuticals, Celgene

ASH® is a registered trademark of the American Society of Hematology. This conference is not sponsored, sanctioned, or part of the 53rd Annual Meeting of the American Society of Hematology.

last updated on Tuesday, November 19, 2013
btn_sharethis